MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-14-2025
NanoVibronix Retained Earnings 2011-2026 | NAOV
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings NanoVibronix
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -69.8 M | -66.1 M | -62.4 M | -56.9 M | - | -38.3 M | -32.5 M | -28.4 M | -22.6 M | -19.7 M | -16.8 M | -14.2 M | -12.2 M | -10.9 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -10.9 M | -69.8 M | -34.7 M |
Quarterly Retained Earnings NanoVibronix
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -76.9 M | -76 M | -72.3 M | -69.8 M | -68.4 M | -67.4 M | -66.7 M | -66.1 M | -65.3 M | -64.6 M | -63.5 M | -62.4 M | -60.3 M | -59.4 M | -58.1 M | -56.9 M | -54.5 M | -47.8 M | -47.6 M | -42.7 M | -42.7 M | -42.7 M | -42.7 M | -38.3 M | -38.3 M | -38.3 M | -38.3 M | -32.5 M | -32.5 M | -32.5 M | -32.5 M | -28.4 M | -28.4 M | -28.4 M | -28.4 M | -22.6 M | -22.6 M | -22.6 M | -22.6 M | -19.7 M | -19.7 M | -19.7 M | -19.7 M | -16.8 M | -16.8 M | -16.8 M | -16.8 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -16.8 M | -76.9 M | -42.7 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 9.23 | -1.6 % | $ 261 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-63.5 M | $ 3.46 | - | $ 130 M |  France |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 12.07 | - | $ 1.63 B | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
FONAR Corporation
FONR
|
-33.6 M | $ 18.6 | - | $ 122 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
2.41 B | $ 36.66 | -0.22 % | $ 5.46 K | USA |
 |
Globus Medical
GMED
|
1.39 B | $ 90.0 | 1.58 % | $ 12.2 B | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 1.81 | -4.74 % | $ 1.1 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
940 M | $ 9.25 | -0.64 % | $ 712 M | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 54.21 | 0.13 % | $ 1.59 B | USA |
 |
Integer Holdings Corporation
ITGR
|
994 M | $ 85.77 | 0.16 % | $ 2.98 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 15.78 | -1.0 % | $ 370 M | USA |
 |
IRIDEX Corporation
IRIX
|
-92.4 M | $ 1.01 | 1.85 % | $ 17.1 M | USA |
 |
LENSAR
LNSR
|
-178 M | $ 5.82 | -1.27 % | $ 69.6 M | USA |
 |
Medtronic PLC
MDT
|
31.5 B | $ 86.12 | -0.19 % | $ 111 B | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
Myomo
MYO
|
-119 M | $ 0.67 | -4.9 % | $ 28 M | USA |
 |
Align Technology
ALGN
|
2.48 B | $ 167.26 | -2.69 % | $ 12.5 B | USA |
 |
AxoGen
AXGN
|
-307 M | $ 31.33 | -4.03 % | $ 1.44 B | USA |
 |
Orthofix Medical
OFIX
|
-368 M | $ 11.58 | -1.61 % | $ 459 M |  Curacao |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Penumbra
PEN
|
238 M | $ 329.2 | -0.2 % | $ 12.8 B | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Insulet Corporation
PODD
|
287 M | $ 203.09 | -0.2 % | $ 14.3 B | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
Sintx Technologies
SINT
|
-292 M | $ 2.49 | -1.58 % | $ 6.91 M | USA |
 |
Butterfly Network
BFLY
|
-802 M | $ 4.03 | -2.42 % | $ 853 M | USA |
 |
Smith & Nephew plc
SNN
|
4.96 B | $ 31.88 | -2.3 % | $ 23.8 B |  Britain |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Stryker Corporation
SYK
|
20.5 B | $ 331.18 | -0.34 % | $ 127 B | USA |
 |
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.59 | 0.69 % | $ 36.7 M | USA |
 |
Tactile Systems Technology
TCMD
|
54.9 M | $ 24.49 | -0.33 % | $ 560 M | USA |
 |
TELA Bio
TELA
|
-398 M | $ 0.62 | -2.08 % | $ 29.1 M | USA |
 |
TransMedics Group
TMDX
|
-278 M | $ 104.84 | 0.04 % | $ 3.56 B | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Tandem Diabetes Care
TNDM
|
-1.25 B | $ 19.55 | 1.98 % | $ 1.33 B | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 9.61 | -0.98 % | $ 344 M | USA |
 |
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
5.57 B | $ 61.27 | -2.11 % | $ 90.7 B | USA |